investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
San Antonio Center For Biomarkers of Risk for Prostate Cancer (SABOR)
Ian M Thompson
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Hyung L Kim
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer
Prostate
Pathology
Ian M Thompson
San Antonio Center for Biomarkers of Risk For Prostate Cancer (SABOR)
Prostate
Pathology
Alexander Robertson Allan Anderson
Predicting Prostate Cancer Aggressiveness
Prostate
Pathology
Clare M Tempany
Enabling Technologies For MRI-Guided Prostate Interventions
Prostate
Pathology
Susan Halabi
Validation of Prognostic and Pathway Signatures in Lethal Prostate Cancer
Prostate
Pathology
Fiona Fennessy
Quantative MRI Of Prostate Cancer as a Biomarker and Guide for Treatment
Prostate
Pathology
Hsian-Rong Tseng
Thermoresponsive Nanovelcro CTC Purification System For Prostate Cancer Profiling
Prostate
Pathology
Patricia Jean Johnson
Trichomonas vaginalis exosomes: Mediators of host:pathogen interactions
Prostate
Pathology
John V Frangioni
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
Prostate
Pathology
